All: how about the other stuff in the PR? First off let me say that it was very foolish and/or penny-wise to try and pack so much unrelated info into one PR. this is just *bad* investor relations, period. Anyways...regarding the content, I've got mixed feelings:
1) the line about "global coverage" has me confused since the previous sentence refers to exchange listings. if BOCX is planning to list us on a foreign exchange i will personally fly to Vancouver with a box of duntz caps for each and every staff member...if i see a berlin listing or other infamous exchange listing, i will debate selling my stock.
what did you guys interpret this sentence to mean?
2) the filing of a new patent related to RECAF is interesting...i know the colorimetric assay is covered in general terms in the original patent, but somehow I have a strong feeling that Moro is hinting that they are nearing the completion of a new test format that is ready for ARCHITECT. there is a good chance IMO the new patent they will file that extends the RECAF life to ~20 yrs is related to the work they've done in preparing the test for ARCHITECT.
3) the whole bit about "know how" and how it relates to licensees and patents is strange...anyone have thoughts on that?
DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.
